Leerink Swann Downgrades Omthera Pharmaceuticals (OMTH) to Market Perform
Tweet
Share
E-mailGet Alerts OMTH Hot Sheet
Price: $13.30 --0%
Rating Summary:
1 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
1 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Leerink Swann downgraded Omthera Pharmaceuticals (NASDAQ: OMTH) from Outperform to Market Perform.
For an analyst ratings summary and ratings history on Omthera Pharmaceuticals click here. For more ratings news on Omthera Pharmaceuticals click here.
Shares of Omthera Pharmaceuticals closed at $13.34 yesterday.
For an analyst ratings summary and ratings history on Omthera Pharmaceuticals click here. For more ratings news on Omthera Pharmaceuticals click here.
Shares of Omthera Pharmaceuticals closed at $13.34 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- RBC Capital Downgrades Accelerant Holdings (ARX) to Sector Perform
- UBS Downgrades ASX Limited (ASX:AU) (ASXFY) to Neutral
- Northcoast Downgrades Brinker Int'l (EAT) to Neutral
Create E-mail Alert Related Categories
DowngradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
